Biological
Invimestrocel clinical trials
Also written MultiStem and HLCM051.
Keep track of what changes. Save the invimestrocel studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
9 studies that test it; most in 2020 (2)
| Year | Studies |
|---|---|
| 2008 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 8 · Other 1
Studies
Open first, then newest update. How each study uses invimestrocel is read from its arms, and is right about nine times in ten.
Testing it · 9
- MultiStem® for Treatment of Trauma Induced Multiple Organ Failure/Systemic Inflammatory Response SyndromeRecruitingPhase 2Healios K.K.NCT04533464Written as MultiStem
- MultiStem Administration for COVID-19 Induced ARDS (MACoVIA)TerminatedPhase 2/3Healios K.K.NCT04367077Written as MultiStem
- MultiStem® Administration for Stroke Treatment and Enhanced Recovery StudyTerminatedPhase 3Healios K.K.NCT03545607Written as MultiStem
- Efficacy and Safety Study of HLCM051(MultiStem®) for Pneumonic Acute Respiratory Distress SyndromeCompletedPhase 2Healios K.K.NCT03807804Written as HLCM051
- Treatment Evaluation of Acute Stroke for Using in Regenerative Cell ElementsCompletedPhase 2/3Healios K.K.NCT02961504Written as HLCM051
- A Phase 1/2 Study to Assess MultiStem® Therapy in Acute Respiratory Distress SyndromeCompletedPhase 1/2Healios K.K.NCT02611609Written as MultiStem
- Safety Study of Multipotent Progenitor Cells for Immunomodulation Therapy After Liver TransplantationTerminatedPhase 1Prof. Dr. Marc-H. Dahlke, Ph. D.NCT01841632Written as MultiStem
- Study to Examine the Effects of MultiStem in Ischemic StrokeCompletedPhase 2Healios K.K.NCT01436487Written as MultiStem
- Safety Study of MultiStem® in Patients With Acute Leukemia, Chronic Myeloid Leukemia, or MyelodysplasiaCompletedPhase 1Healios K.K.NCT00677859Written as MultiStem®
Codes
What other systems call invimestrocel · ClinicalTrials.gg INT018369
- UNII (FDA) WNR9FH307PINVIMESTROCELOne source FDA
- NCI Thesaurus C77874InvimestrocelOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | WNR9FH307P | INVIMESTROCEL | One source FDA |
| NCI Thesaurus | C77874 | Invimestrocel | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.